NASDAQ:MYMD MyMD Pharmaceuticals (MYMD) Stock Price, News & Analysis $0.12 -0.02 (-11.52%) As of 07/25/2025 Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsFDA EventsInsider TradesOptions ChainSEC FilingsTrendsBuy This Stock About MyMD Pharmaceuticals Stock (NASDAQ:MYMD) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get MyMD Pharmaceuticals alerts:Sign Up Key Stats Today's Range$0.11▼$0.1350-Day Range$0.09▼$0.1952-Week Range$1.75▼$63.90Volume48.23 million shsAverage Volume134,123 shsMarket Capitalization$276.82 thousandP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview MyMD Pharmaceuticals, Inc., a clinical development stage pharmaceutical company, focuses on developing various therapeutic platforms to treat the aging and age-related and autoimmune diseases, and chronic pain, anxiety, and sleep disorders. The company is developing MYMD-1, a drug platform based on a clinical stage small molecule that regulates the immune system and its pro-inflammatory cytokines to prevent and treat autoimmune diseases and age-related illnesses, and a Phase 2 clinical trial for sarcopenia, multiple sclerosis, diabetes, inflammatory bowel diseases, and rheumatoid arthritis; inflammation related depression and anxiety; and COVID-19-associated depression. It is also developing Supera-CBD, a synthetic analog of cannabidiol for treating epilepsy, pain, and anxiety/depression. The company was founded in 2014 and is headquartered in Baltimore, Maryland. Read More Receive MYMD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for MyMD Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address MYMD Stock News HeadlinesSarcopenia Clinical Trial Pipeline Appears Robust With 18+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsightApril 24, 2025 | finance.yahoo.comSarcopenia Market Anticipates Impressive Growth Trajectory Across 7MM During the Study Period (2020–2034) | DelveInsightSeptember 25, 2024 | finance.yahoo.comINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.July 29 at 2:00 AM | Traders Agency (Ad)TNF Pharmaceuticals Prepares to Advance Lead Clinical Program Targeting Age-Related DeclineAugust 22, 2024 | finance.yahoo.comTNFA TNF Pharmaceuticals, Inc.August 16, 2024 | seekingalpha.comMyMD Pharmaceuticals Announces Corporate Rebranding to New Name TNF Pharmaceuticals, Inc.July 22, 2024 | businesswire.comMYMD Stock Earnings: MyMD Pharmaceuticals Reported Results for Q1 2024July 15, 2024 | investorplace.comMyMD Pharmaceuticals Appoints Accomplished Biopharmaceutical Leader and Current Board Member, Mitchell Glass, M.D. as President and Chief Medical OfficerJune 17, 2024 | businesswire.comSee More Headlines MYMD Stock Analysis - Frequently Asked Questions How have MYMD shares performed this year? MyMD Pharmaceuticals' stock was trading at $1.15 on January 1st, 2025. Since then, MYMD shares have decreased by 89.8% and is now trading at $0.1168. When did MyMD Pharmaceuticals' stock split? MyMD Pharmaceuticals's stock reverse split before market open on Thursday, February 15th 2024.The 1-30 reverse split was announced on Thursday, February 15th 2024. The number of shares owned by shareholders was adjusted after the market closes on Thursday, February 15th 2024. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split. How do I buy shares of MyMD Pharmaceuticals? Shares of MYMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of MyMD Pharmaceuticals own? Based on aggregate information from My MarketBeat watchlists, some other companies that MyMD Pharmaceuticals investors own include Enovix (ENVX), Rambus (RMBS), Ginkgo Bioworks (DNA), COMPASS Pathways (CMPS), Toast (TOST), NOVONIX (NVNXF) and Globant (GLOB). Company Calendar Today7/28/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Diagnostic substances Sub-IndustryPharmaceutical Products Current SymbolNASDAQ:MYMD CIK1321834 Webwww.mymd.com Phone856-848-8698Fax856-848-0269Employees6Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$4 million Net MarginsN/A Pretax MarginN/A Return on Equity-179.05% Return on Assets-108.14% Debt Debt-to-Equity RatioN/A Current Ratio0.62 Quick Ratio0.62 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$7.21 per share Price / Book0.02Miscellaneous Outstanding Shares2,370,000Free Float2,320,000Market Cap$276.82 thousand OptionableOptionable Beta2.15 Elon Musk's Next MoveExplore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.Get This Free Report This page (NASDAQ:MYMD) was last updated on 7/29/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MyMD Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share MyMD Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.